| mRNA |
BRD-A86708339 |
CTRPv2 |
pan-cancer |
AAC |
-0.0083 |
0.9 |
| mRNA |
LE-135 |
CTRPv2 |
pan-cancer |
AAC |
0.006 |
0.9 |
| mRNA |
Erlotinib |
FIMM |
pan-cancer |
AAC |
0.029 |
0.9 |
| mRNA |
cabozantinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0059 |
0.9 |
| mRNA |
FK866 |
CTRPv2 |
pan-cancer |
AAC |
-0.0061 |
0.9 |
| mRNA |
BRD-K41334119 |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.9 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0057 |
0.9 |
| mRNA |
SGC0946 |
GDSC1000 |
pan-cancer |
AAC |
-0.0056 |
0.9 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0057 |
0.9 |
| mRNA |
CD-437 |
CTRPv2 |
pan-cancer |
AAC |
0.0051 |
0.9 |